[Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients].
METHODS
In a drug monitoring study, 1,334 outpatients with benign prostatic hyperplasia (BPH) were treated for 12 weeks with an extract from the fruits of Sabal serrulata.


RESULTS
Under this treatment, the volume of residual urine decreased by 50%, pollakisuria decreased on average by 37%, and nocturia by 54%. The percentage of patients with dysuric pain decreased from 75% to 37%. The efficacy of the drug was rated good to excellent in more than 80% of the cases, and good to excellent tolerability was reported by more than 95% of the patients.


CONCLUSIONS
The improvement in the irritative symptoms may be considered relevant in terms of improvement in the quality of the life of the patients, and justifies this form of treatment.
Vahlensieck
W
W
Urologische Klinik und Poliklinik, Klinikum Grosshadern der Universität München.
Völp
A
A
Lubos
W
W
Kuntze
M
M
D058891:5-alpha Reductase Inhibitors; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014563:Urodynamics / Q000187:drug effects
D058891:5-alpha Reductase Inhibitors; D010936:Plant Extracts